Overview

A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism

Status:
RECRUITING

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to investigate the safety, tolerability and efficacy of EXT608 in adults with hypoparathyroidism.

Phase:

PHASE2

Details

Lead Sponsor:

Extend Biosciences Inc.